Moreover, increased expression of DSCAM-AS1 was associated with a worse overall survival in breast cancer patients according to our in silico analysis, and knockdown of DSCAM-AS1 inhibited breast cancer cell proliferation, increased apoptosis and inhibited cell cycle progression in this study. This evidence concerns the gene DSCAM-AS1 and breast carcinoma.